LONDON and NEW YORK, April 27,
2015 /PRNewswire/ --
The recently published report, 'India Joint Replacement - Market
Size, Procedure Volume, Growth Trend at City, State and National
Level' provides a detailed analysis of joint replacement surgeries
in 740 hospitals from more than 200 cities. It reviews market
drivers, restraints, historical trends and forecasts (for the
period from 2007 to 2020), annualised trends for sales in terms of
value and volume (in dollar terms and units), market growth,
pricing, competitive landscape and market share. It offers a
cross-category comparison for THR and TKR (Total Hip Replacement
and Total Knee Replacement) as well as shoulder joint replacement
for the historical and forecast period.
(Photo:
http://photos.prnewswire.com/prnh/20150427/740870 )
Why one should buy this report
- To get a detailed analysis of the joint replacement market and
joint replacement surgeries for over 740 hospitals in more than 200
cities.
- To make a regional strategy based on regional landscape and
regional market characteristics.
- To capitalise on opportunities in high-growth regions and
attractive joint arthroplasty markets.
- To understand market dynamics at macro and micro level by
analysing city and nation level trends.
- To plan and make capital investments based on the forecast for
high potential joint replacement segments.
- To prepare management and strategic presentations for the
investors and shareholders.
The joint replacement market in India grew in double digits between 2007 and
2014. The joint replacement market comprises Total Hip Replacement
(THR), Total Knee Replacement (TKR), partial knee replacement,
partial hip replacement, shoulder joint replacement and other small
joint replacement surgeries. Of these, THR and TKR account for the
bulk of revenues.
The key factors fuelling the growth of joint replacement
surgeries in India are an
increasing number of trained joint replacement surgeons, aging
population, sedentary lifestyle, rising health care expenditure,
improved healthcare infrastructure and medical tourism. Improved
implant designs and a wide choice of implants have also helped
surgeons choose the implant that best suits the needs of each
patient.
As per ABMRG's study, in India
most people above 60 years suffer from some kind of bone and joint
disease and many of them have an immediate need for joint
replacement surgery. High prevalence of arthritis primarily in
north and south India and
increasing prevalence of osteoporosis among post-menopausal women
in urban areas who follow a sedentary lifestyle have stimulated the
growth of the joint replacement market. Availability of trained
orthopaedic surgeons and improved facilities in hospitals have also
increased the number of patients opting for joint replacement
surgeries. Unlike in western countries, in India the fear of failure of surgery and
post-surgery infections among the patients do not affect the joint
replacement market as most patients are ignorant about
complications and history of product recalls.
India has also witnessed a boom
in medical tourism over the years due to longer waiting time for
joint replacement in European countries, very limited availability
of doctors with expertise in joint replacement procedures in
Africa and the Middle East and low procedure costs for joint
replacement surgeries in India. In
addition to cost benefits, a large number of NRIs prefer to get the
procedure done in India as they
have high level of confidence in Indian surgeons' expertise.
The Indian joint replacement market is packed with local and
multinational companies. Despite higher prices and a history of
product recalls, MNCs dominate the Indian market due to surgeons'
preference and patients' desire for imported implants. In mid to
long term, we expect local companies to steal the market share from
MNCs. However, MNCs are anticipated to lead the rally at least for
another decade.
The key players in the India
joint replacement market are Aesculap, a division of B. Braun
Melsungen AG; Biomet, Inc.; Orthovasive, a division of Biorad
Medisys Pvt. Ltd; DePuy Medical Pty. Ltd, a subsidiary of Johnson
& Johnson (NYSE: JNJ); Exatech, Inc.; Maxx Medical Pvt. Ltd;
Smith & Nephew plc (NYSE: SNN; LSE: SN); Stryker Corporation
(NYSE: SYK) and Zimmer Holdings Inc (NYSE: ZMH, Nasdaq: ZMH).
The report on joint replacements in India also outlines joint replacement product
pipeline and highlights findings of global clinical studies. In
addition, it lists developments in the global industry over the
last two years, including M&As, partnerships, clinical studies,
pipelines, product approvals and launches, recalls and litigations,
market dynamics, market drivers and restrains.
Other strategic market reports:
- APAC Joint Replacement And Joint Reconstruction Market Through
2020
http://www.abmrg.com/APAC-Joint-Replacement-And-Joint-Reconstruction-Market-Through-2020.html
- Australia Joint Reconstruction Market Outlook, 2007-2020
http://www.abmrg.com/Australia-Joint-Reconstruction-Market-Outlook-2007-2020.html
- UK Joint Reconstruction Market Forecast To 2020
http://www.abmrg.com/UK-Joint-Reconstruction-Market-Forecast-To-2020.html
- India Joint Reconstruction Market Trends Forecast To 2020
http://www.abmrg.com/India-Joint-Reconstruction-Market-Trends-Forecast-To-2020.html
- European Hip Replacement Market Through 2020- Opportunities,
Trends and Pipeline Analysis
http://www.abmrg.com/European-Hip-Replacement-Market-Through-2020---Opportunities-Trends-And-Pipeline-Analysis.html
About ABMRG
ABMRG (Ace Business and Market Research Group) is a research and
consulting firm focused on medical technology and pharmaceuticals.
It offers comprehensive research and analytical studies targeting
company, country and therapeutic sector, highlighting market
dynamics, vital trends, business strategies, clinical pipeline and
technology advancements. Its cutting edge reports empower companies
to make smarter, effective and faster strategic decisions for
business growth.
Contact:
Ankit Jian
+91-8238155239
+91-261-2216406
sales@abmrg.com
19@abmrg.com
SOURCE ABMRG